Efalizumab monoclonal antibody drug. Targets CD11a but was withdrawn from the market due to safety issues. Generic name and stylized antibody.

---

Size: 9000px × 5020px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: antibody, autoimmune, biological, biosimilar, biotech, biotechnology, cd11a, disease, drug, efalizumab, immunoglobulin, immunology, infusion, injection, inn, mab, monoclonal, nomenclature, peptide, protein, psoriasis, recombinant, withdrawn